Sildenafil Injection, Solution
Product Images NDC 55150-166

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 55150-166). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1: Kaplan-meier Plot Of Mortality By Sildenafil Dose (Sildenafil Fig1)

FDA Label Image

Figure 2. Effects Of Other Drugs On Sildenafil Pharmacokinetics (Sildenafil Fig2)

FDA Label Image

Figure 3. Effects Of Sildenafil On Other Drugs (Sildenafil Fig3)

FDA Label Image

Figure 4. Change From Baseline In 6-minute Walk Distance (meters) At Weeks 4, 8, And 12 In Study 1: Mean (95% Confidence Interval) (Sildenafil Fig4)

Figure 4. Change From Baseline In 6-minute Walk Distance (meters) At Weeks 4, 8, And 12 In Study 1: Mean (95% Confidence Interval) (Sildenafil Fig4)
Not available. The text appears to be a jumbled combination of characters and words with no coherent meaning.*
FDA Label Image

Figure 5. Placebo-corrected Change From Baseline In 6-minute Walk Distance (meters) At Week 12 By Study Subpopulation In Study 1: Mean (95% Confidence Interval) (Sildenafil Fig5)

FDA Label Image

Figure 6. Kaplan-meier Plot Of Time (in Days) To Clinical Worsening Of Pah In Study 2 (Sildenafil Fig6)

FDA Label Image

Figure 7. Mean Change From Baseline In Six Minute Walk (meters) By Visit To Week 12 – Itt Population Sildenafil Protocol A1481244 (Sildenafil Fig7)

Figure 7. Mean Change From Baseline In Six Minute Walk (meters) By Visit To Week 12 – Itt Population Sildenafil Protocol A1481244 (Sildenafil Fig7)
The text describes a plot that shows the mean change from baseline (in meters) with the standard error for each treatment and visit up to week 12. It also includes some random characters and possibly missing information.*
FDA Label Image

Package Label-principal Display Panel (10 mg per 12.5 mL)

Package Label-principal Display Panel (10 mg per 12.5 mL)
This is a description of a medication called Sildenafil Injection. It comes in a sterile single-dose vial containing 10mg per 12.5mL of solution. It is intended for intravenous use and the unused portion is to be discarded. Each mL of solution has 1.124mg of sildenafil citrate USP equivalent to 0.8mg sildenafil and 50.5mg dextrose and Water for Injection. The vial stopper is made without natural rubber latex. Recommended usual dosage is included in the prescription information that accompanies the medication. It is distributed by AuroMedics Pharma LLC in Windsor, NJ, and is made in India. It must be stored between 68" to 77°F.*
FDA Label Image

Package Label-principal Display Panel (10 mg per 12.5 mL)

Package Label-principal Display Panel (10 mg per 12.5 mL)
This is a drug information sheet for Sildenafil Injection, manufactured by AuroMedics Pharma LLC. It is an intravenous medication that comes in a 12.5 mL single-dose vial, with 10mg of Sildenafil per mL. The medication is used for erectile dysfunction and high blood pressure in the lungs. The typical dosage is not provided and should follow the prescribing information. The packaging and storage recommendations are also provided. Overall, it is an informational document for medical professionals.*
FDA Label Image

Sildenafil Citrate Chemical Structure (Sildenafil Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.